338103 <common-name>N-[2-chloro-5-(trifluoromethyl)phenyl]-2-[[4-(4-ethoxyphenyl)-5-pyridin-3-yl-1,2,4-triazol-3-yl]sulfanyl]acetamide</common-name> <description>N-[2-chloro-5-(trifluoromethyl)phenyl]-2-[[4-(4-ethoxyphenyl)-5-pyridin-3-yl-1,2,4-triazol-3-yl]sulfanyl]acetamide is a chemical compound with the formula C24H19ClF3N5O2S. With an average molecular weight of 534.00 g/mol, N-[2-chloro-5-(trifluoromethyl)phenyl]-2-[[4-(4-ethoxyphenyl)-5-pyridin-3-yl-1,2,4-triazol-3-yl]sulfanyl]acetamide is a heavy molecule.</description> <cas>477330-00-0</cas> <pubchem-id>1417580</pubchem-id> <chemical-formula>C24H19ClF3N5O2S</chemical-formula> <weight>534</weight> <appearance nil="true"/> <melting-point nil="true"/> <boiling-point nil="true"/> <density nil="true"/> <solubility nil="true"/> <specific-gravity nil="true"/> <flash-point nil="true"/> <vapour-pressure nil="true"/> <route-of-exposure nil="true"/> <target nil="true"/> <mechanism-of-toxicity nil="true"/> <metabolism nil="true"/> <toxicity nil="true"/> <lethaldose nil="true"/> <carcinogenicity nil="true"/> <use-source nil="true"/> <min-risk-level nil="true"/> <health-effects nil="true"/> <symptoms nil="true"/> <treatment nil="true"/> <created-at type="dateTime">2026-08-30T21:09:12Z</created-at> <updated-at type="dateTime">2026-08-30T21:09:12Z</updated-at> <interacting-proteins nil="true"/> <wikipedia nil="true"/> <uniprot-id nil="true"/> <kegg-compound-id nil="true"/> <omim-id nil="true"/> <chebi-id nil="true"/> <biocyc-id nil="true"/> <ctd-id nil="true"/> <stitch-id nil="true"/> <drugbank-id nil="true"/> <pdb-id nil="true"/> <actor-id nil="true"/> <organism nil="true"/> <export type="boolean">true</export> <metabolizing-proteins nil="true"/> <transporting-proteins nil="true"/> <moldb-smiles>CCOC1=CC=C(C=C1)N2C(=NN=C2SCC(=O)NC3=C(C=CC(=C3)C(F)(F)F)Cl)C4=CN=CC=C4</moldb-smiles> <moldb-formula>C24H19ClF3N5O2S</moldb-formula> <moldb-inchi>InChI=1S/C24H19ClF3N5O2S/c1-2-35-18-8-6-17(7-9-18)33-22(15-4-3-11-29-13-15)31-32-23(33)36-14-21(34)30-20-12-16(24(26,27)28)5-10-19(20)25/h3-13H,2,14H2,1H3,(H,30,34)</moldb-inchi> <moldb-inchikey>ZXGCVQOBICXBLJ-UHFFFAOYSA-N</moldb-inchikey> <moldb-average-mass type="decimal" nil="true"/> <moldb-mono-mass type="decimal">533.0900082</moldb-mono-mass> <origin nil="true"/> <state nil="true"/> <logp>5.3</logp> <hmdb-id nil="true"/> <chembl-id nil="true"/> <chemspider-id nil="true"/> <structure-image-file-name nil="true"/> <structure-image-content-type nil="true"/> <structure-image-file-size type="integer" nil="true"/> <structure-image-updated-at type="dateTime" nil="true"/> <biodb-id nil="true"/> <synthesis-reference nil="true"/> <structure-image-caption nil="true"/> <chemdb-id>CHEM333996</chemdb-id> <dsstox-id nil="true"/> <toxcast-id nil="true"/> <stoff-ident-origin nil="true"/> <stoff-ident-id nil="true"/> <susdat-id nil="true"/> <iupac>N-[2-chloro-5-(trifluoromethyl)phenyl]-2-[[4-(4-ethoxyphenyl)-5-pyridin-3-yl-1,2,4-triazol-3-yl]sulfanyl]acetamide</iupac> <moldb-polar-surface-area nil="true"/> <moldb-refractivity nil="true"/> <moldb-polarizability nil="true"/> <moldb-rotatable-bond-count nil="true"/> <moldb-acceptor-count nil="true"/> <moldb-donor-count nil="true"/> <moldb-pka-strongest-acidic nil="true"/> <moldb-pka-strongest-basic nil="true"/> <moldb-physiological-charge nil="true"/> <moldb-number-of-rings nil="true"/> <moldb-alogps-logp nil="true"/> <moldb-alogps-logs nil="true"/> <moldb-alogps-solubility nil="true"/> <kingdom>Organic compounds</kingdom> <superklass>Organoheterocyclic compounds</superklass> <klass>Pyridines and derivatives</klass> <subklass>Pyridyltriazoles</subklass> <paper-count type="integer" nil="true"/> <sync-id>CED0288532</sync-id> <structure-inchikey>ZXGCVQOBICXBLJ-UHFFFAOYSA-N</structure-inchikey> <structure-fingerprint>40002004008800020028000000000000000000000000000044000040000000020000002000040080020020800000000000040000000000000000000000000000004000000000000200000000200020000001000002000080100000000000000140000000000000001000000000000001000000000000000000000000001000400000008000000000000000808800000100000002800200000800000000000000000000000000000800000000400000004d0000000000002c00200100000000000020001000000000000000500010000000002000000200000000000000008040000000002040000000000400800008010000000040000000000000</structure-fingerprint> <structure-pattern-fingerprint>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</structure-pattern-fingerprint> <structure-pickle type="binary" encoding="base64">776t3gAAAAAQAAAAAwAAAAAAAAAkAAAAJwAAAIABBgBgAAAAAQMGAGAAAAAC AggAKAAAAAMCBkAoAAAAAwQGQGgAAAADAwEGQGgAAAADAwEGQCgAAAADBAZA aAAAAAMDAQZAaAAAAAMDAQdAKAAAAAMDBkAoAAAAAwQHQCgAAAADAwdAKAAA AAMDBkAoAAAAAwQQACAAAAACBgBgAAAAAgIGACgAAAADBAgAKAAAAAMCBwBo AAAAAwIBBkAoAAAAAwQGQCgAAAADBAZAaAAAAAMDAQZAaAAAAAMDAQZAKAAA AAMEBkBoAAAAAwMBBgAgAAAABAkAIAAAAAEJACAAAAABCQAgAAAAAREAIAAA AAEGQCgAAAADBAZAaAAAAAMDAQdAKAAAAAMDBkBoAAAAAwMBBkBoAAAAAwMB BkBoAAAAAwMBCwABAAECAAIDIAMEaAwEBWgMBQZoDAYHaAwHCGgMBgkgCQpo DAoLaAwLDGgMDA1oDA0OAA4PAA8QABARKAIQEiASEyATFGgMFBVoDBUWaAwW F2gMFxhoDBcZABkaABkbABkcABQdAAoeIB4faAwfIGgMICFoDCEiaAwiI2gM CANoDA0JaAwYE2gMIx5oDEIEAAAABgMIBwYFBAULCgkNDAYUFRYXGBMGHyAh IiMeFwQAAAAAAAAAFg== </structure-pickle> <structure-indexed-at type="dateTime">2026-09-19T05:38:58Z</structure-indexed-at> </compound>